QuickView for CYP1B1;jsessionid=3953E34A356F416CB15FC0085D20B0B2;jsessionid=0635DA906C0EFAE788421E90FF3005D6;jsessionid=B30E8BEFE29661F7E037F1E6C59CD002;jsessionid=E2E0D02BEE2ACDF4D2DE1AF6ADBFF40D;jsessionid=4CE1F2DE8AD90516DE3985AF5458A02B (gene)

No studies found

1. Variable Phenotype of Congenital Corneal Opacities in Biallelic CYP1B1 Pathogenic Variants.
2. Development of novel N-aryl-2,4-bithiazole-2-amine-based CYP1B1 degraders for reversing drug resista…
3. Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic st…
4. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enant…
5. Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel…

There were no clinical trials for CYP1B1;jsessionid=3953E34A356F416CB15FC0085D20B0B2;jsessionid=0635DA906C0EFAE788421E90FF3005D6;jsessionid=B30E8BEFE29661F7E037F1E6C59CD002;jsessionid=E2E0D02BEE2ACDF4D2DE1AF6ADBFF40D;jsessionid=4CE1F2DE8AD90516DE3985AF5458A02B